论文部分内容阅读
目的:评价雷贝拉唑联合西沙必利治疗功能性消化不良(FD)的疗效。方法:将280例FD患者随机分为2组,口服雷贝拉唑和西沙必利140例(观察组),口服奥美拉唑140例(对照组)。疗程均为2周。观察2组患者胃部烧灼感、餐后饱胀、上腹痛及嗳气等症状改善程度。结果:2组治疗前后胃部烧灼感、上腹痛症状评分下降差异均有统计学意义(P<0.05);治疗后2组比较,差异均无统计学意义(P>0.05)。嗳气、餐后饱胀症状评分观察组下降差异有统计学意义(P<0.05);而对照组下降差异无统计学意义(P>0.05)。结论:雷贝拉唑联合西沙必利治疗FD疗效肯定,在治疗胃部烧灼感、上腹痛症状与奥美拉唑用药效果相近,而在治疗嗳气、餐后饱胀症状优于奥美拉唑,而且用药不良反应少,可作为治疗FD首选用药。
Objective: To evaluate the efficacy of rabeprazole combined with cisapride in the treatment of functional dyspepsia (FD). Methods: A total of 280 patients with FD were randomly divided into 2 groups: oral rabeprazole and cisapride in 140 cases (observation group) and oral omeprazole in 140 cases (control group). The course of treatment is 2 weeks. Two groups of patients were observed in the stomach burning sensation, postprandial fullness, upper abdominal pain and belching and other symptoms improved. Results: There were significant differences in the scores of burning sensation of the stomach and upper abdominal pain between the two groups before and after treatment (P <0.05). There was no significant difference between the two groups after treatment (P> 0.05). (P <0.05), while there was no significant difference between the control group and the observation group (P> 0.05). Conclusion: Rabeprazole combined with cisapride in the treatment of FD affirmative effect in the treatment of stomach burning sensation, upper abdominal pain and omeprazole medication similar results, and in the treatment of belching, postprandial fullness symptoms better than omeprazole , And less adverse drug reactions, FD can be used as the treatment of choice medication.